S. Cho
Molecular Biology · Genome Research · 2013–2018
A researcher in the Science corpus: 7 papers; trusts 3 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 148 citations into it; #5,656 of 17,773 by trust here, #2,214 by citations
- Plant Science — 24 citations into it
- Business and International Management — 9 citations into it
Whom S. Cho trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Cho overall
- Sojung Kim
- Christopher A. Lino
- Haifeng Wang
- Matthew H. Larson
- Luke A. Gilbert
- Jennifer A. Doudna
- Sangsu Bae
- Jeongbin Park
- P. Mali
- Jin-Soo Kim
Papers from S. Cho's perspective
Ordered by how strongly the researchers S. Cho trusts endorse each paper. Same corpus, a different order for every researcher.
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors (Science)
- CRISPR/Cas, the Immune System of Bacteria and Archaea (Science)
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease (Nature Biotechnology)
- Highly efficient endogenous human gene correction using designed zinc-finger nucleases (Nature)
- Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease (Genetics)
- An improved zinc-finger nuclease architecture for highly specific genome editing (Nature Biotechnology)
- Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos (Cell Research)
- CRISPR-assisted editing of bacterial genomes (Nature Biotechnology)
- RNA-Guided Human Genome Engineering via Cas9
- Enhancing Gene Targeting with Designed Zinc Finger Nucleases (Science)
Their papers
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease (2013) — 1,899 citations
- Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases (2014) — 1,407 citations
- An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues (2017) — 2,152 citations
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins (2014) — 1,716 citations
- The chromatin accessibility landscape of primary human cancers (2018) — 1,069 citations
- DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins (2015) — 1,064 citations
- CRISPRi-based genome-scale identification of functional long non-coding RNA loci in human cells (2016) — 636 citations